Lymphoma, Follicular: all 964 studies
Page 2 of 10. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.
- Zanubrutinib Plus GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Follicular LymphomaNot yet recruitingNCT06918015Phase 2
- A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)RecruitingNCT06911502Phase 3
- Combating Cancer-Related Fatigue: A Personalized Supportive Care ProgramRecruitingNCT06860880Not applicable
- Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or AstrocytomaRecruitingNCT06860594Phase 1
- Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin LymphomaRecruitingNCT06859008Phase 1
- Pain With DementiaRecruitingNCT06854718Not applicable
- CD70-targeted immunoPET Imaging of Malignant CancersRecruitingNCT06852638Phase 2
- Mindfulness-Based Cognitive Therapy (MBCT) for the Prevention of Depression Relapse or Recurrence Using VideoconferenceRecruitingNCT06832605Not applicable
- STimulation to Activate RespIrationRecruitingNCT06832306Not applicable
- Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular LymphomaRecruitingNCT06830759
- Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular LymphomaRecruitingNCT06826118Phase 2
- Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant AstrocytomaRecruitingNCT06815029Phase 1
- A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing SettingRecruitingNCT06794268
- HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZLRecruitingNCT06792825Phase 2
- Long-term Follow up Local Registry Study of Kymriah in South KoreaRecruitingNCT06785818
- Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NETRecruitingNCT06784752Phase 3
- Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T TreatmentRecruitingNCT06784167
- Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular LymphomaNot yet recruitingNCT06757894Phase 2
- A Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat AccumulationRecruitingNCT06756490Phase 1
- Tau PET Outcomes With Anti-amyloid ImmunotherapiesEnrolling by invitationNCT06723015Phase 2
- Q702 for the Treatment of Patients With Hematologic MalignanciesRecruitingNCT06712810Phase 1
- Radiotherapy Followed by Tiselizumab Combined With RCHOP in Previously Untreated Bulky Follicular LymphomaRecruitingNCT06704555Phase 2
- A Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological MalignanciesRecruitingNCT06703892Phase 1
- Evaluation of CO-OP for Adolescents With Mild Intellectual DisabilityRecruitingNCT06691698Not applicable
- Chronic CED of TPT for Recurrent Malignant GliomaRecruitingNCT06666712Phase 1
- Development of Pressure Sensor Based Dementia and Fall Prevention Program for Older AdultsRecruitingNCT06664229Not applicable
- Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use DisorderRecruitingNCT06651177Phase 2
- MOLyF : Bone Marrow and Follicular LymphomaRecruitingNCT06608147Not applicable
- Drinking, Acetate, and StressRecruitingNCT06584448Not applicable
- Buddy-Up Dyadic Physical Activity Program for Persons With Dementia and Family CaregiversRecruitingNCT06584110Not applicable
- Epco, Zanu, Ritux for R/R FL or MZLRecruitingNCT06563596Phase 2
- Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular LymphomaRecruitingNCT06553352Phase 2
- Emapalumab Prevention of CAR-T Cell Associated ToxicitiesRecruitingNCT06550141Phase 2
- A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma PatientsRecruitingNCT06549595Phase 3
- Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL)Not yet recruitingNCT06549335Phase 2
- Long-term Follow-up of Gene Therapy for Radiation-Induced XerostomiaEnrolling by invitationNCT06544798Phase 2
- SynKIR-310 for Relapsed/Refractory B-NHLRecruitingNCT06544265Phase 1
- A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.RecruitingNCT06542250Phase 1/2
- Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)RecruitingNCT06533579Phase 1/2
- Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHLRecruitingNCT06526793Phase 2
- Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront ChemoimmunotherapyRecruitingNCT06510361Phase 2
- STEpwise Research Program to Promote INGeniouS ONline Supportive Solutions in the Relief of Cancer-related FatigueRecruitingNCT06505590Not applicable
- Zanubrutinib and G-CHOP in Untreated Intermediate-high Risk Follicular LymphomaNot yet recruitingNCT06474481Phase 2
- Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular LymphomaRecruitingNCT06471738Phase 2
- Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial CancerRecruitingNCT06468215Not applicable
- Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular LymphomaRecruitingNCT06453044Phase 2
- Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell LymphomaRecruitingNCT06442475Phase 2
- A Prospective Analysis of the Efficacy of Allosync Expand and Autograft Bone Graft in Open Lumbar Spinal FusionEnrolling by invitationNCT06415110
- Deep Phenotyping for Clinical Inferring Response in Treatment Resistant DepressionRecruitingNCT06396312
- A Phase II Study of SHR2554 in Patients With Relapsed or Refractory Follicular LymphomaNot yet recruitingNCT06368167Phase 2
- Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)RecruitingNCT06362707Phase 2
- Rituximab and Zanubrutinib in Patients With Indolent B-cell LymphomasRecruitingNCT06350318Phase 2
- AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell LymphomasRecruitingNCT06340737Phase 1
- Autonomic Involvement in Patient With Cognitive DeclineRecruitingNCT06292741Not applicable
- Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCLRecruitingNCT06287398Phase 2
- Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).RecruitingNCT06213636Phase 1/2
- B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic MalignanciesRecruitingNCT06191887Phase 1
- Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular LymphomaRecruitingNCT06158386Phase 2
- Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FLRecruitingNCT06151080Phase 2
- A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone LymphomaRecruitingNCT06149286Phase 3
- Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a SolutionRecruitingNCT06131801
- Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular LymphomaRecruitingNCT06108232Phase 2
- A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular LymphomaRecruitingNCT06091254Phase 3
- Assessing the Experience of Patients Undergoing Follicular Lymphoma Clinical ResearchNot yet recruitingNCT06049485
- A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell MalignanciesRecruitingNCT06045910Phase 1/2
- A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular LymphomaRecruitingNCT06043323Phase 2
- Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic NeoplasmsRecruitingNCT06043011
- CD79b-19 CAR T Cells in Non-Hodgkin LymphomaRecruitingNCT06026319Phase 1
- A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.RecruitingNCT06022029Phase 1
- LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell MalignanciesRecruitingNCT05990465Phase 1
- A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)RecruitingNCT05984147Phase 1
- rTMS and Cognitive-behavioral Therapy for Cocaine Use DisorderRecruitingNCT05974202Not applicable
- Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain InjuryRecruitingNCT05951777Phase 2
- Hypnosis: a Path to AppeasementRecruitingNCT05942885Not applicable
- Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana LinfomiRecruitingNCT05929222Phase 3
- A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FLRecruitingNCT05899621
- Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic CountriesRecruitingNCT05849857Phase 2
- Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapyRecruitingNCT05848765Phase 2
- Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Follicular Lymphoma in Real World StudyRecruitingNCT05846763
- Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell LymphomaRecruitingNCT05826535Phase 1/2
- Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From FIL_FOLL12 TrialRecruitingNCT05816850
- Allo HSCT Using RIC and PTCy for Hematological DiseasesRecruitingNCT05805605Phase 2
- Epcoritamab and Rituximab for First-line Follicular LymphomaRecruitingNCT05783609Phase 2
- A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell MalignanciesRecruitingNCT05780034Phase 1
- Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene CiloleucelAvailableNCT05776160
- A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed GlioblastomaRecruitingNCT05765812Phase 1/2
- Early Detection and Screening of Hematological Malignancies - SANGUINERecruitingNCT05735704
- A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell MalignanciesRecruitingNCT05643742Phase 1/2
- A Compassionate Use (CU) Program of OdronextamabAvailableNCT05619367
- Long-term Ovarian Fertility in Patients Treated for Lymphoma.RecruitingNCT05616325
- AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin LymphomaRecruitingNCT05602363Phase 1
- CBT and the Neural Circuits of AnxietyRecruitingNCT05549102
- Study of SGR-1505 in Mature B-Cell NeoplasmsRecruitingNCT05544019Phase 1
- Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte MalignanciesRecruitingNCT05541341
- Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU TrialRecruitingNCT05496998Not applicable
- A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular LymphomaRecruitingNCT05389293Phase 2
- IKS03 in Patients With Advanced B Cell Non-Hodgkin LymphomasRecruitingNCT05365659Phase 1
- Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular LymphomaRecruitingNCT05326308
- SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)RecruitingNCT05303519Phase 3
- Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-DegraderRecruitingNCT05294731Phase 1/2